Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Tactile Medical signs exclusive US distribution deal for ElastiMed's MyoSleeve device

Neutral Impact 3 of 5 product/contract Written later

Tactile Systems Technology (Tactile Medical) entered an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device, covering Department of Veterans Affairs and Department of Defense patients. The company paid an upfront $3 million and committed to certain minimum purchase obligations and marketing support, and the filing gives no revenue or financial outlook for the deal.

Key points

  • Exclusive U.S. distribution rights for MyoSleeve within the VA and DoD systems, announced July 13, 2026
  • Upfront payment of $3 million to ElastiMed, plus undisclosed minimum purchase and marketing commitments
  • MyoSleeve has FDA 510(k) clearance for chronic swelling, including chronic edema, lymphedema and venous insufficiency

The filing

CompanyTACTILE SYSTEMS TECHNOLOGY INC (TCMD)
Form8-K, current report
Filed with the SECJul 13, 2026, 9:23 AM ET
Accession number0001104659-26-082947

Items reported: 7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.